Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.

@article{Amsterdam2010EfficacyAS,
  title={Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.},
  author={Jay D. Amsterdam and Justine Shults},
  journal={The American journal of psychiatry},
  year={2010},
  volume={167 7},
  pages={792-800}
}
OBJECTIVE The authors examined the safety and efficacy of long-term fluoxetine monotherapy, lithium monotherapy, and placebo therapy in preventing relapse and recurrence of bipolar type II major depressive episode. The authors hypothesized that fluoxetine monotherapy would be superior to lithium monotherapy with a similar hypomanic mood conversion rate. METHOD Patients at least 18 years old who recovered from their major depressive episode during initial open-label fluoxetine monotherapy were… CONTINUE READING